Previous panel (unchanged since 2019) | |||
---|---|---|---|
Pharmaceutical | FMCG | Luxury | |
3 French companies | Danone | Kering LVMH | |
5 European companies (excl. France) | GSK | Beiersdorf Reckitt Benckiser Unilever Henkel | |
5 US companies | Colgate PalmoliveKimberley Clark Kenvue (Johnson & Johnson) Procter & Gamble | Estée Lauder | |
Total13 companies | 1 | 9 | 3 |
Adjusted panel (2025) | |||
---|---|---|---|
Pharmaceutical | FMCG | Luxury | |
3 French companies |
KeringLVMH
Essilor Luxottica |
||
5 European companies (excl. France) |
GSK
Novartis |
BeiersdorfUnilever Henkel | |
5 US companies |
Colgate Palmolive
Pepsico Kenvue (Johnson & Johnson) Procter & Gamble |
Estée Lauder | |
Total 13 companies | 2 | 7 | 4 |
Previous panel (median)
Sales*
€30,100m
Number of employees*
88,800
Market capitalisation**
€87,600m
L’Oréal
Sales*
€41,183m
Number of employees*
94,605
Market capitalisation**
€205,180m
Adjusted panel (median)
Sales*
€34,898m
Number of employees*
88,843
Market capitalisation**
€95,490m
Companies exiting the 2025 Panel
Companies entering the 2025 Panel
Remuneration that is aligned with the best interests of the Company and directly linked to its strategy
The Board of Directors has aligned the remuneration policy for the executive corporate officer in line with the interests of the Company in order to ensure its long-term sustainability and development, taking into consideration the social and environmental challenges of its business activity and L'Oréal's Sense of Purpose.
a) Close links with strategy
The remuneration policy applied to the executive corporate officer is directly linked to the Group’s strategy. It supports its development model. It promotes harmonious, regular, durable growth, both over the short and long term. The Board of Directors strives constantly to encourage General Management to maximise performance for each financial year and to ensure that this performance is repeated and regular year after year. This is in line with L’Oréal’s objective of economic and societal excellence.